Healthcare
Healthcare
FDA Greenlights Eli Lilly’s Alzheimer’s Drug Donanemab
On Tuesday, the Food and Drug Administration (FDA) granted approval for Eli Lilly’s Alzheimer’s drug, donanemab, marking a significant milestone in the treatment...
New, Deadly Mpox Variant Sparks Global Outbreak Concerns
Health experts and the World Health Organization have issued warnings about a dangerous new strain of mpox, currently causing a severe outbreak in...
Lawsuits Claim Baby Bottle Makers Misled on Microplastic Risks
Philips North America and Handi-Craft Company, the parent company of Dr. Brown’s Baby, face separate lawsuits filed Tuesday alleging that their baby bottles,...
Weight Loss Drugs May Reduce Bone Density: Study
A recent study published in the journal JAMA Network indicates that medications such as Ozempic and Wegovy, popular for weight loss, may lead...
Cosmetic Surgery Booms in 2023 Amid Weight Loss Drug Surge
In a comprehensive report analyzing trends in cosmetic surgery, 2023 saw a significant uptick in procedures such as fillers, Botox injections, facelifts, and...
Wegovy Approved in China, Novo Nordisk Prioritizes Patient Supply
Ozempic manufacturer Novo Nordisk announced on Tuesday that its popular weight loss drug Wegovy has been approved for sale in China. This approval...
FDA Approves Menthol Vapes Amid Cigarette Ban Delays
On Friday, the Food and Drug Administration (FDA) approved the first-ever menthol-flavored vapes, allowing four NJOY menthol e-cigarettes to enter the market. NJOY,...
Zealand Pharma Shares Surge 17% on Positive Drug Trial
Shares of Zealand Pharma soared by over 17% on Friday following the announcement of positive trial results for petrelintide, a potential competitor to...
Eli Lilly Warns of Lawsuits Over Counterfeit Weight-Loss Drugs
Several medical spas and wellness centers face potential lawsuits from Eli Lilly for allegedly selling compounded and counterfeit versions of popular weight loss...
Telehealth Execs’ Arrests May Deepen ADHD Drug Shortage
The recent arrests of two high-ranking executives from a prominent telehealth medication company could exacerbate an already-existing shortage of ADHD medications, potentially affecting...
